| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-1A adrenergic receptor binding | 2.48e-05 | 2 | 100 | 2 | GO:0031691 | |
| GeneOntologyMolecularFunction | follicle-stimulating hormone receptor binding | 7.42e-05 | 3 | 100 | 2 | GO:0031762 | |
| GeneOntologyMolecularFunction | alpha-1B adrenergic receptor binding | 7.42e-05 | 3 | 100 | 2 | GO:0031692 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNB XIRP1 MAP1B AXL KIF1B ADD1 KIF20A SETD2 SAG MAP1S SVIL PHACTR4 STAU2 SCN5A SSH2 MTUS2 | 1.09e-04 | 1099 | 100 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 2.29e-04 | 172 | 100 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | phospholipid binding | 4.23e-04 | 548 | 100 | 10 | GO:0005543 | |
| GeneOntologyCellularComponent | retromer complex | 1.33e-04 | 21 | 100 | 3 | GO:0030904 | |
| GeneOntologyCellularComponent | costamere | 1.53e-04 | 22 | 100 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | dendrite | CACNA1B ILK MAP1B PCLO KIF1B KCNB2 ADD1 ARRB1 ARRB2 MAP1S PRKAA2 STAU2 SNX1 | 2.25e-04 | 858 | 100 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1B FLNB ILK MAP1B PCLO KIF1B KCNB2 ADD1 ARRB1 ARRB2 MAP1S PRKAA2 STAU2 KCNQ1 SNX1 SOS1 | 2.29e-04 | 1228 | 100 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1B ILK MAP1B PCLO KIF1B KCNB2 ADD1 ARRB1 ARRB2 MAP1S PRKAA2 STAU2 SNX1 | 2.30e-04 | 860 | 100 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | microtubule minus-end | 4.68e-04 | 7 | 100 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | supramolecular fiber | FLNB ILK MAP1B KIF1B NCKAP5 CMYA5 KIF20A MAP1S SVIL STAU2 SCN5A ASPM AKAP13 MTUS2 NPNT | 4.72e-04 | 1179 | 100 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | FLNB ILK MAP1B KIF1B NCKAP5 CMYA5 KIF20A MAP1S SVIL STAU2 SCN5A ASPM AKAP13 MTUS2 NPNT | 5.06e-04 | 1187 | 100 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule end | 7.94e-04 | 38 | 100 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | microtubule | 1.04e-03 | 533 | 100 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | centriole | 1.43e-03 | 172 | 100 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.71e-03 | 13 | 100 | 2 | GO:1990907 | |
| MousePheno | abnormal extracellular matrix morphology | 3.41e-05 | 100 | 86 | 6 | MP:0013258 | |
| MousePheno | abnormal muscle fiber morphology | XIRP1 MAGEL2 COL15A1 ANO5 CMYA5 USP19 MAP1S SCN5A BUB1B AKAP13 SOS1 | 3.74e-05 | 406 | 86 | 11 | MP:0004087 |
| Domain | Arrestin_N | 5.76e-07 | 4 | 99 | 3 | IPR014753 | |
| Domain | Arrestin_CS | 5.76e-07 | 4 | 99 | 3 | IPR017864 | |
| Domain | ARRESTINS | 5.76e-07 | 4 | 99 | 3 | PS00295 | |
| Domain | Arrestin | 5.76e-07 | 4 | 99 | 3 | IPR000698 | |
| Domain | - | 5.76e-07 | 4 | 99 | 3 | 2.60.40.840 | |
| Domain | - | 4.98e-06 | 7 | 99 | 3 | 2.60.40.640 | |
| Domain | Arrestin_C | 7.94e-06 | 8 | 99 | 3 | IPR014752 | |
| Domain | Arrestin-like_N | 1.69e-05 | 10 | 99 | 3 | IPR011021 | |
| Domain | Arrestin_C-like | 1.69e-05 | 10 | 99 | 3 | IPR011022 | |
| Domain | Arrestin_C | 1.69e-05 | 10 | 99 | 3 | SM01017 | |
| Domain | Arrestin_C | 1.69e-05 | 10 | 99 | 3 | PF02752 | |
| Domain | Arrestin_N | 1.69e-05 | 10 | 99 | 3 | PF00339 | |
| Domain | MAP1 | 8.32e-05 | 3 | 99 | 2 | IPR026074 | |
| Domain | Ion_trans_dom | 3.51e-04 | 114 | 99 | 5 | IPR005821 | |
| Domain | Ion_trans | 3.51e-04 | 114 | 99 | 5 | PF00520 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SFSWAP JADE3 KIF1B YTHDC2 CHD7 BCL9 USP19 ADD1 C2CD5 SETD2 EPS15L1 MAP1S SVIL PHACTR4 YY1AP1 SOS1 | 7.36e-10 | 774 | 100 | 16 | 15302935 |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 10549660 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 1458825 | ||
| Pubmed | Prolonged photoresponses in transgenic mouse rods lacking arrestin. | 2.31e-08 | 3 | 100 | 3 | 9333241 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAPKAP1 ILK MAP1B KIF1B DYRK4 TRIP11 DENND4C MAST4 SVIL PHACTR4 PRKAA2 BUB1B AKAP13 MPHOSPH9 SSH2 | 2.56e-08 | 861 | 100 | 15 | 36931259 |
| Pubmed | FLNB MAP1B JADE3 BCORL1 DENND4C KIF20A EPS15L1 ARRB2 BUB1B MPHOSPH9 MED23 CABIN1 SNX1 | 4.42e-08 | 645 | 100 | 13 | 25281560 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10508404 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | JADE3 MAP4K3 VPS13C KIF1B LONP1 EPS15L1 MAST4 SVIL PHACTR4 BUB1B TNRC6A POC5 MPHOSPH9 HERC2 | 1.61e-07 | 853 | 100 | 14 | 28718761 |
| Pubmed | MAP4K3 TOM1L1 NCKAP5 ARRB1 ARRB2 TNRC6A AKAP13 YY1AP1 MPHOSPH9 HERC2 SOS1 | 1.64e-07 | 486 | 100 | 11 | 20936779 | |
| Pubmed | 1.72e-07 | 209 | 100 | 8 | 36779422 | ||
| Pubmed | Dopamine receptor D4 internalization requires a beta-arrestin and a visual arrestin. | 2.30e-07 | 5 | 100 | 3 | 26169958 | |
| Pubmed | SFSWAP VPS13C KIF1B MUC16 TRIP11 USP19 ADD1 KIF20A EPS15L1 PHACTR4 TNRC6A MPHOSPH9 SNX1 | 3.73e-07 | 777 | 100 | 13 | 35844135 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 3.82e-07 | 232 | 100 | 8 | 25515538 | |
| Pubmed | XIRP1 ILK MAP1B BCORL1 PFAS KIF20A LONP1 EPS15L1 SVIL AKAP13 POC5 SSH2 | 7.12e-07 | 689 | 100 | 12 | 36543142 | |
| Pubmed | FLNB VPS39 KIF1B NCKAP5 CMYA5 TRIP11 EPS15L1 ARRB1 MAP1S YY1AP1 HERC2 CABIN1 MPPED2 MTUS2 SNX1 SOS1 | 7.97e-07 | 1285 | 100 | 16 | 35914814 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 30366904 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ILK MAP1B JADE3 MAP4K3 AXL PRX C2CD5 AXIN2 ITPR2 MAP1S PRKAA2 BUB1B SOS1 | 2.16e-06 | 910 | 100 | 13 | 36736316 |
| Pubmed | 2.79e-06 | 34 | 100 | 4 | 26378152 | ||
| Pubmed | FLNB MAP1B MAP4K3 PCLO KIF1B YTHDC2 TRIP11 ADD1 LRCH3 ITPR2 LONP1 EPS15L1 MAP1S SVIL SSH2 MTUS2 | 3.20e-06 | 1431 | 100 | 16 | 37142655 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VPS39 PFAS ZNF395 BCL9 ITPR2 HIVEP3 EPS15L1 MAP1S SCN5A AKAP13 HERC2 ZC3H7B CABIN1 CYB5R2 | 3.43e-06 | 1105 | 100 | 14 | 35748872 |
| Pubmed | 3.69e-06 | 421 | 100 | 9 | 36976175 | ||
| Pubmed | TOM1L1 CLEC1A ANO5 CMYA5 TRIP11 DENND4C LRCH3 PHACTR4 PRKAA2 MANSC4 POC5 | 4.69e-06 | 686 | 100 | 11 | 29987050 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.27e-06 | 440 | 100 | 9 | 34244565 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | MAP4K3 VPS39 VPS13C EI24 DENND4C C2CD5 EPS15L1 PHACTR4 STAU2 TNRC6A HERC2 | 7.30e-06 | 719 | 100 | 11 | 35337019 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF1B BCORL1 PFAS CHD7 PGAM2 TRIP11 SETD2 TNRC6A ASPM YY1AP1 | 7.83e-06 | 588 | 100 | 10 | 38580884 |
| Pubmed | Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. | 8.18e-06 | 2 | 100 | 2 | 18703513 | |
| Pubmed | Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. | 8.18e-06 | 2 | 100 | 2 | 17579607 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15541899 | ||
| Pubmed | Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function. | 8.18e-06 | 2 | 100 | 2 | 28973019 | |
| Pubmed | β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. | 8.18e-06 | 2 | 100 | 2 | 26077142 | |
| Pubmed | Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. | 8.18e-06 | 2 | 100 | 2 | 17426148 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34344831 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21543334 | ||
| Pubmed | LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1. | 8.18e-06 | 2 | 100 | 2 | 34480046 | |
| Pubmed | ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation. | 8.18e-06 | 2 | 100 | 2 | 36215165 | |
| Pubmed | Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. | 8.18e-06 | 2 | 100 | 2 | 17618287 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26103985 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34450275 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32948676 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9668034 | ||
| Pubmed | Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice. | 8.18e-06 | 2 | 100 | 2 | 31622341 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16181421 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17544529 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34843966 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23853484 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21855149 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18519945 | ||
| Pubmed | Regulation of mitochondrial oxidative stress by β-arrestins in cultured human cardiac fibroblasts. | 8.18e-06 | 2 | 100 | 2 | 26449263 | |
| Pubmed | The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling. | 8.18e-06 | 2 | 100 | 2 | 17594911 | |
| Pubmed | Light-dependent regulation of the transcriptional activity of the mammalian gene for arrestin. | 8.18e-06 | 2 | 100 | 2 | 7932878 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12582207 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26927499 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22699970 | ||
| Pubmed | beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. | 8.18e-06 | 2 | 100 | 2 | 19349687 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21411739 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23631430 | ||
| Pubmed | The Two β-Arrestins Regulate Distinct Metabolic Processes: Studies with Novel Mutant Mouse Models. | 8.18e-06 | 2 | 100 | 2 | 35008921 | |
| Pubmed | Deficiency of β-Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases. | 8.18e-06 | 2 | 100 | 2 | 30541881 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25134464 | ||
| Pubmed | beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. | 8.18e-06 | 2 | 100 | 2 | 11171997 | |
| Pubmed | Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. | 8.18e-06 | 2 | 100 | 2 | 20589830 | |
| Pubmed | Control of rhodopsin's active lifetime by arrestin-1 expression in mammalian rods. | 8.18e-06 | 2 | 100 | 2 | 20203204 | |
| Pubmed | β-Arrestin2 mediates the initiation and progression of myeloid leukemia. | 8.18e-06 | 2 | 100 | 2 | 22773819 | |
| Pubmed | Staufen 2 regulates mGluR long-term depression and Map1b mRNA distribution in hippocampal neurons. | 8.18e-06 | 2 | 100 | 2 | 21508097 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17418896 | ||
| Pubmed | β-Arrestin2 mediates progression of murine primary myelofibrosis. | 8.18e-06 | 2 | 100 | 2 | 29263312 | |
| Pubmed | β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer. | 8.18e-06 | 2 | 100 | 2 | 30787175 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19896992 | ||
| Pubmed | Functional comparisons of visual arrestins in rod photoreceptors of transgenic mice. | 8.18e-06 | 2 | 100 | 2 | 17460248 | |
| Pubmed | Unique Roles of β-Arrestin in GPCR Trafficking Revealed by Photoinducible Dimerizers. | 8.18e-06 | 2 | 100 | 2 | 29330504 | |
| Pubmed | Deactivation of phosphorylated and nonphosphorylated rhodopsin by arrestin splice variants. | 8.18e-06 | 2 | 100 | 2 | 16421323 | |
| Pubmed | Histone methyltransferase SETD2 is required for meiotic maturation in mouse oocyte. | 8.18e-06 | 2 | 100 | 2 | 30078214 | |
| Pubmed | β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy. | 8.18e-06 | 2 | 100 | 2 | 27054338 | |
| Pubmed | Transduction of group I mGluR-mediated synaptic plasticity by β-arrestin2 signalling. | 8.18e-06 | 2 | 100 | 2 | 27886171 | |
| Pubmed | Hepatic β-arrestin 2 is essential for maintaining euglycemia. | 8.18e-06 | 2 | 100 | 2 | 28650340 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8486659 | ||
| Pubmed | Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade. | 8.18e-06 | 2 | 100 | 2 | 34507982 | |
| Pubmed | β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids. | 8.18e-06 | 2 | 100 | 2 | 32027601 | |
| Pubmed | Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A. | 8.18e-06 | 2 | 100 | 2 | 12820704 | |
| Pubmed | β-arrestins negatively control human adrenomedullin type 1-receptor internalization. | 8.18e-06 | 2 | 100 | 2 | 28427767 | |
| Pubmed | VPS13C EI24 CHD7 DENND4C ADD1 ITPR2 SETD2 TNRC6A AKAP13 POC5 MPHOSPH9 | 8.75e-06 | 733 | 100 | 11 | 34672954 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 9.64e-06 | 256 | 100 | 7 | 33397691 | |
| Pubmed | MAPKAP1 AXL TOM1L1 KIAA0586 PFAS USP19 EPS15L1 PRKAA2 HERC2 MTUS2 | 9.88e-06 | 604 | 100 | 10 | 38803224 | |
| Pubmed | 1.43e-05 | 106 | 100 | 5 | 18654987 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.71e-05 | 110 | 100 | 5 | 37219487 | |
| Pubmed | MAPKAP1 MAP1B EI24 PFAS YTHDC2 BUB1B AKAP13 YY1AP1 GAPDHS ZC3H7B | 1.86e-05 | 650 | 100 | 10 | 38777146 | |
| Pubmed | 2.11e-05 | 56 | 100 | 4 | 34170322 | ||
| Pubmed | Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. | 2.45e-05 | 3 | 100 | 2 | 18787115 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 31696929 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 17194706 | ||
| Pubmed | Pygopus residues required for its binding to Legless are critical for transcription and development. | 2.45e-05 | 3 | 100 | 2 | 14612447 | |
| Pubmed | Identification of receptor binding-induced conformational changes in non-visual arrestins. | 2.45e-05 | 3 | 100 | 2 | 24867953 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22882672 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 26211463 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 17161064 | ||
| Pubmed | β-Arrestin signal complex plays a critical role in adipose differentiation. | 2.45e-05 | 3 | 100 | 2 | 23557604 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 7695743 | ||
| Pubmed | Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome. | 2.45e-05 | 3 | 100 | 2 | 15534720 | |
| Pubmed | Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. | 2.45e-05 | 3 | 100 | 2 | 15367556 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 11136691 | ||
| Interaction | CALM3 interactions | FLNB AXL VPS13C KIF1B DENND4C LRCH3 ITPR2 ARRB1 ARRB2 SVIL ASPM POC5 | 1.20e-07 | 343 | 99 | 12 | int:CALM3 |
| Interaction | MED4 interactions | FLNB MAP1B TRIP11 DENND4C EPS15L1 ARRB2 BUB1B TNRC6A POC5 MPHOSPH9 HERC2 MED23 SNX1 | 3.12e-07 | 450 | 99 | 13 | int:MED4 |
| Interaction | ZYX interactions | KIAA0586 ARRB1 SVIL BUB1B TNRC6A AKAP13 POC5 MPHOSPH9 SSH2 ZC3H7B | 5.05e-06 | 329 | 99 | 10 | int:ZYX |
| Interaction | TRIP13 interactions | 1.01e-05 | 281 | 99 | 9 | int:TRIP13 | |
| Interaction | CALM1 interactions | VPS13C KIF1B DENND4C ADD1 LRCH3 KIF20A SVIL PHACTR4 SCN5A ASPM POC5 HERC2 CABIN1 | 1.18e-05 | 626 | 99 | 13 | int:CALM1 |
| Interaction | SAG interactions | 1.35e-05 | 10 | 99 | 3 | int:SAG | |
| Interaction | GSK3B interactions | ILK MAP1B KIAA0586 PFAS YTHDC2 DENND4C ADD1 AXIN2 ARRB1 ARRB2 MAST4 PRKAA2 STAU2 TNRC6A HERC2 | 2.12e-05 | 868 | 99 | 15 | int:GSK3B |
| Interaction | ARRDC4 interactions | 5.54e-05 | 83 | 99 | 5 | int:ARRDC4 | |
| Interaction | CSK interactions | ILK TOM1L1 CLEC1A ANO5 CMYA5 TRIP11 DENND4C LRCH3 ARRB1 ARRB2 PHACTR4 PRKAA2 MANSC4 POC5 | 7.89e-05 | 861 | 99 | 14 | int:CSK |
| Interaction | TNFRSF1B interactions | 8.40e-05 | 146 | 99 | 6 | int:TNFRSF1B | |
| Interaction | GSK3A interactions | KIAA0586 PFAS YTHDC2 DENND4C ADD1 AXIN2 ARRB2 MAST4 STAU2 TNRC6A | 9.50e-05 | 464 | 99 | 10 | int:GSK3A |
| GeneFamily | Classical arrestins | 1.46e-07 | 4 | 61 | 3 | 1312 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | MAGEL2 MAP1B JADE3 PCLO KIF1B KIAA0586 NCKAP5 CHD7 PGAM2 HIVEP3 FEZF1 STAU2 ASPM LHX5 MPPED2 FGF19 | 1.09e-05 | 986 | 98 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.07e-10 | 195 | 100 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.17e-08 | 190 | 100 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.32e-08 | 193 | 100 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-07 | 170 | 100 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.84e-07 | 182 | 100 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.06e-07 | 185 | 100 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-07 | 187 | 100 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.55e-07 | 191 | 100 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.55e-07 | 191 | 100 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.64e-07 | 192 | 100 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.84e-07 | 194 | 100 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.94e-07 | 195 | 100 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 170 | 100 | 6 | d99f61aa85ea3f775165cb433421e6f1cda4f96b | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 170 | 100 | 6 | 615cf9639c66b3fbd984ebe3f345280005d3c38a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.40e-06 | 181 | 100 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.74e-06 | 184 | 100 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-06 | 187 | 100 | 6 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.10e-06 | 187 | 100 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-06 | 187 | 100 | 6 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 188 | 100 | 6 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 188 | 100 | 6 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 188 | 100 | 6 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 188 | 100 | 6 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 188 | 100 | 6 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 4.36e-06 | 189 | 100 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.36e-06 | 189 | 100 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 189 | 100 | 6 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 189 | 100 | 6 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.36e-06 | 189 | 100 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.49e-06 | 190 | 100 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.49e-06 | 190 | 100 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.49e-06 | 190 | 100 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 191 | 100 | 6 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 191 | 100 | 6 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 191 | 100 | 6 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 191 | 100 | 6 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 192 | 100 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-06 | 194 | 100 | 6 | 93bc72a933ccc6a760e5353f072afb606571c6fc | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.06e-06 | 194 | 100 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.22e-06 | 195 | 100 | 6 | dabf667875ed48fdce4f803f5ead39c71a6df42b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 196 | 100 | 6 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 196 | 100 | 6 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 196 | 100 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 5.86e-06 | 199 | 100 | 6 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Club-club-1|World / Class top | 6.67e-06 | 54 | 100 | 4 | 48f80b20b1c4995a0f7084d31666781dce4009a9 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 157 | 100 | 5 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 157 | 100 | 5 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.76e-05 | 167 | 100 | 5 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 170 | 100 | 5 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 170 | 100 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | 26bba58f9fb215d1d155504906cd77e8774f6936 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | 69b404e92aad3e6dff67e75466f073f20a71f13f | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 4.70e-05 | 175 | 100 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.70e-05 | 175 | 100 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 4.70e-05 | 175 | 100 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.82e-05 | 176 | 100 | 5 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.82e-05 | 176 | 100 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-05 | 177 | 100 | 5 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-05 | 177 | 100 | 5 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-05 | 178 | 100 | 5 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 5.37e-05 | 180 | 100 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 181 | 100 | 5 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 181 | 100 | 5 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 5.66e-05 | 182 | 100 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | 75608f80fd570da499891dc02f8649d5428b896c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 182 | 100 | 5 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 182 | 100 | 5 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 182 | 100 | 5 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.66e-05 | 182 | 100 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.80e-05 | 183 | 100 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-05 | 183 | 100 | 5 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-05 | 183 | 100 | 5 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.96e-05 | 184 | 100 | 5 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-05 | 184 | 100 | 5 | 5cfc19ffb9f074bdf0d81c86e212a708ec141631 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.96e-05 | 184 | 100 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.27e-05 | 186 | 100 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.27e-05 | 186 | 100 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.27e-05 | 186 | 100 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-05 | 187 | 100 | 5 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-05 | 187 | 100 | 5 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.59e-05 | 188 | 100 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.59e-05 | 188 | 100 | 5 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 192 | 100 | 5 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-05 | 192 | 100 | 5 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 7.28e-05 | 192 | 100 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| Drug | 2,2,2-trifluoroethanethiol | 8.17e-07 | 5 | 100 | 3 | CID004133924 | |
| Drug | sulfo-SADP | 2.84e-06 | 7 | 100 | 3 | CID000128116 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.19e-05 | 174 | 100 | 7 | 7530_DN | |
| Drug | aluminum(III) chloride | 1.32e-05 | 11 | 100 | 3 | CID006451240 | |
| Drug | ddeCyd | 1.76e-05 | 12 | 100 | 3 | CID000064683 | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 2.25e-05 | 192 | 100 | 7 | 1599_DN | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.32e-05 | 193 | 100 | 7 | 4978_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A | 2.56e-05 | 196 | 100 | 7 | 2005_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; HL60; HG-U133A | 2.83e-05 | 199 | 100 | 7 | 1391_DN | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; HL60; HT_HG-U133A | 2.92e-05 | 200 | 100 | 7 | 2167_UP | |
| Drug | CTK8F0943 | 4.42e-05 | 16 | 100 | 3 | CID010062692 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 2.88e-05 | 18 | 99 | 3 | C0342384 | |
| Disease | neutrophil count | FLNB KIF1B BCORL1 CHD7 BCL9 ITPR2 HIVEP3 SETD2 EPS15L1 TNRC6A AKAP13 YY1AP1 POC5 SSH2 FGF19 | 5.64e-05 | 1382 | 99 | 15 | EFO_0004833 |
| Disease | Paroxysmal familial ventricular fibrillation | 6.66e-05 | 4 | 99 | 2 | C0340493 | |
| Disease | body weight | CACNA1B VPS13C TOM1L1 ANO5 CHD7 KCNB2 AXIN2 SETD2 MAST4 FEZF1 TNRC6A KCNQ1 POC5 MPPED2 | 8.05e-05 | 1261 | 99 | 14 | EFO_0004338 |
| Disease | long QT syndrome (is_implicated_in) | 2.31e-04 | 7 | 99 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | Embryonal Rhabdomyosarcoma | 3.08e-04 | 8 | 99 | 2 | C0206656 | |
| Disease | lymphocyte count | FLNB PCDHGC5 KIF1B CHD7 AKR1C4 ZNF395 ITPR2 SETD2 EPS15L1 SAG ARRB2 PRKAA2 SSH2 ZC3H7B | 3.76e-04 | 1464 | 99 | 14 | EFO_0004587 |
| Disease | electrocardiography | 4.21e-04 | 530 | 99 | 8 | EFO_0004327 | |
| Disease | cholesteryl ester 20:5 measurement | 4.39e-04 | 44 | 99 | 3 | EFO_0010349 | |
| Disease | Gastric Adenocarcinoma | 4.69e-04 | 45 | 99 | 3 | C0278701 | |
| Disease | PRADER-WILLI SYNDROME | 4.93e-04 | 10 | 99 | 2 | 176270 | |
| Disease | Prader-Willi syndrome | 4.93e-04 | 10 | 99 | 2 | cv:C0032897 | |
| Disease | age at onset, multiple sclerosis | 4.93e-04 | 10 | 99 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | selective IgA deficiency disease | 5.01e-04 | 46 | 99 | 3 | EFO_1001929 | |
| Disease | comparative body size at age 10, self-reported | 5.45e-04 | 420 | 99 | 7 | EFO_0009819 | |
| Disease | multiple myeloma | 5.61e-04 | 112 | 99 | 4 | EFO_0001378 | |
| Disease | HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA | 6.01e-04 | 11 | 99 | 2 | 146110 | |
| Disease | Hypogonadotropic hypogonadism 7 with or without anosmia | 6.01e-04 | 11 | 99 | 2 | cv:C0342384 | |
| Disease | Congenital long QT syndrome | 6.01e-04 | 11 | 99 | 2 | cv:C1141890 | |
| Disease | Long QT Syndrome | 6.01e-04 | 11 | 99 | 2 | C0023976 | |
| Disease | Royer Syndrome | 7.20e-04 | 12 | 99 | 2 | C0265222 | |
| Disease | Long QT syndrome | 7.20e-04 | 12 | 99 | 2 | cv:C0023976 | |
| Disease | monocyte percentage of leukocytes | 7.97e-04 | 731 | 99 | 9 | EFO_0007989 | |
| Disease | Prader-Willi Syndrome | 8.48e-04 | 13 | 99 | 2 | C0032897 | |
| Disease | T wave morphology measurement | 9.88e-04 | 14 | 99 | 2 | EFO_0008398 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 9.88e-04 | 14 | 99 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | neutrophil percentage of granulocytes | 1.05e-03 | 228 | 99 | 5 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 1.17e-03 | 234 | 99 | 5 | EFO_0007996 | |
| Disease | myeloid white cell count | 1.21e-03 | 937 | 99 | 10 | EFO_0007988 | |
| Disease | Romano-Ward Syndrome | 1.30e-03 | 16 | 99 | 2 | C0035828 | |
| Disease | anthranilic acid measurement | 1.30e-03 | 16 | 99 | 2 | EFO_0010460 | |
| Disease | response to acetylsalicylate | 1.30e-03 | 16 | 99 | 2 | GO_1903492 | |
| Disease | S-6-hydroxywarfarin measurement | 1.53e-03 | 368 | 99 | 6 | EFO_0803326 | |
| Disease | photoreceptor cell layer thickness measurement | 1.58e-03 | 148 | 99 | 4 | EFO_0803370 | |
| Disease | Liver carcinoma | 1.62e-03 | 507 | 99 | 7 | C2239176 | |
| Disease | cortical surface area measurement | FLNB KIF1B NCKAP5 CHD7 MAST4 STAU2 TNRC6A MPHOSPH9 SSH2 MED23 MPPED2 SOS1 | 1.82e-03 | 1345 | 99 | 12 | EFO_0010736 |
| Disease | Disproportionate short stature | 2.24e-03 | 77 | 99 | 3 | C0878659 | |
| Disease | Joubert syndrome 1 | 2.24e-03 | 21 | 99 | 2 | C4551568 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 2.46e-03 | 22 | 99 | 2 | C1843687 | |
| Disease | Cardiomegaly | 2.68e-03 | 82 | 99 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.68e-03 | 82 | 99 | 3 | C1383860 | |
| Disease | neuroimaging measurement | MAP1B KIF1B NCKAP5 ARMC9 CHD7 DENND4C MAST4 TNRC6A SSH2 MPPED2 | 3.16e-03 | 1069 | 99 | 10 | EFO_0004346 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFHEIMSLKDLPSDP | 621 | O60566 | |
| LHFPMALKPGETPLP | 116 | P17516 | |
| LSMPPPKFHDTSSPL | 96 | Q9UBC2 | |
| PKFHDTSSPLMVTPP | 101 | Q9UBC2 | |
| MPIKESDIPRPKHTP | 151 | Q75V66 | |
| THFSKIPIEPVESMP | 371 | Q58F21 | |
| HPERMPPLIADSPKA | 366 | P54646 | |
| MPELPLLPHDSHPKE | 1006 | Q5H9F3 | |
| HPHPVVPKMEKELVP | 761 | Q12802 | |
| KEDVPFPLMAGPTVP | 191 | C9JDP6 | |
| HRLPKEMTPVEPATF | 356 | Q9Y2T1 | |
| PMFFPLEPSAPSKLH | 476 | O76090 | |
| PFRLMHPQPEDPAKE | 356 | P10523 | |
| TLDLLVPPHKPDEMT | 1836 | Q00975 | |
| HSPSEPFLEKPVPDM | 556 | Q9P2D1 | |
| GPTHTLELMPPDSFK | 301 | Q8N608 | |
| KPLKTDIPRHPMPFA | 671 | Q8IZT6 | |
| ELPFTLMHPKPKEEP | 346 | P49407 | |
| LMHPKPKEEPPHREV | 351 | P49407 | |
| VSVELPFVLMHPKPH | 336 | P32121 | |
| PPTCTMPLPHEEKAA | 671 | Q5JR59 | |
| GFVTADMIKEHLPPP | 226 | Q6BCY4 | |
| MSVPDVPPSIHPSKQ | 941 | Q14571 | |
| VHMVDPIPYDTPKPA | 41 | Q15777 | |
| IPSEMPTPPKTSHGE | 11946 | Q8WXI7 | |
| PVLSPRKPSHPVMDF | 106 | Q8NA72 | |
| PPKPKSIFIPQEMHS | 436 | Q8IVH8 | |
| KMLTVPHITCDPPEE | 436 | P51787 | |
| PSIHVPSPAVPKLTM | 701 | Q96II8 | |
| KTVTYKHMDPPPAPV | 2191 | P46821 | |
| EHRKAVPMAPAPASP | 746 | Q66K74 | |
| MLPSTFPLLPEDPHD | 406 | Q8TC57 | |
| KGQPPVPHEIPTSME | 591 | Q9UJ55 | |
| IPKVMIEPSGPIHVP | 256 | Q6UXI9 | |
| LTTPIMFPPEHPVEE | 1421 | O95714 | |
| PLPPELLPTEMEKTH | 801 | O60333 | |
| LPFVPNPMVHPSFKE | 151 | Q7Z3E5 | |
| VHIPGSPFKADIEMP | 1116 | O75369 | |
| VLHPDMAKVPPASPK | 3656 | Q9Y6V0 | |
| PEEMPKSSDFLIHPP | 671 | Q9Y5F6 | |
| PLSHFLPMLPMVPEE | 161 | O95750 | |
| FITHISKMEPAAVPP | 1331 | Q9ULK4 | |
| PPEVLTLDPTLHMKP | 286 | Q99550 | |
| LSGMPPVSFPAVHKP | 366 | Q8N8W4 | |
| FEPIDTKLSHMPVPP | 236 | A6NHS7 | |
| FTDMISHPDTPSPEP | 341 | Q9H2C1 | |
| ALTPMTIPDVFPHLP | 111 | P36776 | |
| PGKHEIQPPMPTVVF | 571 | Q6W3E5 | |
| TPSLTHMVPAKQPPI | 246 | Q8IZ21 | |
| MGSKTLPAPVPIHPS | 1 | Q8TAX0 | |
| SHLTEFAPPPTPMVD | 56 | Q9BRQ0 | |
| MPASELKASEIPFHP | 1 | Q9NR20 | |
| LPPPSASHLQMKFPT | 621 | Q92953 | |
| HPTESSSPPPEKAPM | 191 | Q8WV28 | |
| PQVKMAPTSSPAEPH | 2036 | Q9Y6J0 | |
| PHPFPSVSKIIADML | 161 | O14681 | |
| IPPNHKAPLTMASPA | 946 | O00512 | |
| LVSEKPFPPHMSPEV | 541 | Q8N3K9 | |
| PTIPPGISPHVCKLM | 411 | Q13418 | |
| QKSEHTVFIMPPEPP | 681 | Q5VZ89 | |
| DPQEPTHSKPLAPME | 631 | Q96P31 | |
| ELDHILSPPPMPFRK | 121 | O15021 | |
| HPATPPPKMVSVARE | 61 | O14556 | |
| IFPIPVRPHCKMPVD | 956 | P39059 | |
| PSHPFPPAKAMTVEK | 836 | Q86YS7 | |
| QPSPKKPDHPLMVSA | 1546 | Q9C0B2 | |
| PERMEPITKISHIPP | 291 | Q92613 | |
| DVPIPMASTTHPEKP | 546 | Q2WGJ9 | |
| MLEPEHTPVAQEPPK | 1166 | Q2WGJ9 | |
| VPSDVELPPTAKMHA | 196 | Q12872 | |
| LPPLPSNHPAMTKSD | 421 | O75674 | |
| PPITHLGDEPKEFSM | 1006 | O95425 | |
| PSVAFKKPIFTHPMP | 996 | O14513 | |
| KKPIFTHPMPSPEAV | 1001 | O14513 | |
| RRSFDIPPPPMDEKH | 116 | P15259 | |
| IMARTPEPKALPVPH | 36 | A0PJY2 | |
| PVMLEHPPDTTTPSE | 621 | Q14524 | |
| VDLEKIHPPSMPGDS | 36 | Q9BPZ7 | |
| IMSKHLDSPPAIPPR | 1171 | Q07889 | |
| PMLEKEEEAHRPPSP | 656 | P35611 | |
| AGMVKPESLHVPPET | 261 | Q8NC01 | |
| LVSKATHMKPPRTPP | 431 | Q9NQ32 | |
| KHMKPSVEPAPPVSR | 116 | O60930 | |
| ETHLASPKPTCMVPP | 456 | O94966 | |
| FIVPPPPEKSLIGMT | 206 | Q13596 | |
| MPVSFEVIKESGPPH | 221 | Q9NUL3 | |
| IAEVKTMESHPPIPP | 491 | Q76I76 | |
| MLEPPPSAKPFTIDV | 716 | O95235 | |
| PKVPEMAVPDVHLPE | 606 | Q9BXM0 | |
| LPKVPEMAVPDVHLP | 641 | Q9BXM0 | |
| HPIQSFSPESMPEPL | 156 | O15067 | |
| TPAFMSPGKPEHLLE | 101 | Q5T1R4 | |
| PAPAMKSHLIVTSPP | 456 | Q9H8N7 | |
| ESFPAPVVILPFMKH | 611 | P30530 | |
| AMFPVVFHPVAPPKS | 3216 | Q709C8 | |
| HTPITVLMAAPVPLP | 216 | Q9BYW2 | |
| EAPPSKMVLRIPHPI | 486 | Q9H869 | |
| ADFLMKAPEPPPALI | 791 | Q9H6S0 | |
| IPPPKLSVHDMKPLD | 1876 | Q15643 | |
| PETPSCPVKHTLMPE | 446 | Q00G26 | |
| PTESIIHVPPLDPSM | 966 | Q702N8 | |
| MPHTTPELQKGPSPI | 1491 | Q8NDV7 | |
| MPPAGVIVSKPHPVT | 746 | Q9BVV6 | |
| MHDAFEPVPILEKLP | 1 | Q96JC1 | |
| LPSTPTMPLFPHVLD | 221 | Q9UGR2 |